Kasvu Therapeutics Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $34.5M

  • Investors
  • 7

Kasvu Therapeutics General Information

Description

Operator of a drug development company designed to create rapid-acting neuroplastogens for the treatment of mental, behavioral, and neurodevelopmental disorders. The company offers potent, rapid-acting, and long-lasting neuroplasticity enhancers that improve neurodegenerative conditions such as Alzheimer's and Parkinson's disease without causing the hallucinations associated with psychedelics, enabling healthcare providers to effectively address conditions like post-traumatic stress disorder and addiction, enhancing patient well-being.

Contact Information

Website
www.kasvutx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • C/O Jami Mandelin Kuulijantie 28 B
  • 00730 Helsinki
  • Finland
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech
Corporate Office
  • C/O Jami Mandelin Kuulijantie 28 B
  • 00730 Helsinki
  • Finland

Kasvu Therapeutics Timeline

202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kasvu Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series A) 30-Jun-2026 $34.5M Completed Pre-Clinical Trials
3. Seed Round 23-Sep-2024 Completed Pre-Clinical Trials
2. Seed Round 20-Oct-2023 $1.3M $1.3M Completed Pre-Clinical Trials
1. University Spin-Out 01-Jan-2023 Completed Pre-Clinical Trials
To view Kasvu Therapeutics’s complete valuation and funding history, request access »

Kasvu Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series Seed Shares
Series Seed Shares
To view Kasvu Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Kasvu Therapeutics Patents

  • 4

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 4

    Pending

  • Expiring in next 12 mo

Kasvu Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202507048-D0 Compounds Pending 08-May-2025
GB-202507049-D0 Compounds Pending 08-May-2025
WO-2026234272-A1 Compounds Pending 08-May-2025
WO-2026234274-A1 Compounds Pending 08-May-2025

Kasvu Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kasvu Therapeutics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Finnish Drug Discovery Center Corporation Minority
Hadean Ventures Venture Capital Minority
Stephen Industries Venture Capital Minority
Tesi Limited Partner Minority
Nordic Science Investments Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

Kasvu Therapeutics FAQs

  • When was Kasvu Therapeutics founded?

    Kasvu Therapeutics was founded in 2023.

  • Where is Kasvu Therapeutics headquartered?

    Kasvu Therapeutics is headquartered in Helsinki, Finland.

  • What is the size of Kasvu Therapeutics?

    Kasvu Therapeutics has 10 total employees.

  • What industry is Kasvu Therapeutics in?

    Kasvu Therapeutics’s primary industry is Drug Discovery.

  • Is Kasvu Therapeutics a private or public company?

    Kasvu Therapeutics is a Private company.

  • What is the current valuation of Kasvu Therapeutics?

    The current valuation of Kasvu Therapeutics is .

  • What is Kasvu Therapeutics’s current revenue?

    The current revenue for Kasvu Therapeutics is .

  • How much funding has Kasvu Therapeutics raised over time?

    Kasvu Therapeutics has raised $41.1M.

  • Who are Kasvu Therapeutics’s investors?

    Finnish Drug Discovery Center, Hadean Ventures, Stephen Industries, Tesi, and Nordic Science Investments are 5 of 7 investors who have invested in Kasvu Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process